Close Menu

University of Manchester

University of Manchester researchers describe their design for DNA computing, according to Popular Mechanics.

The circulating tumor cell-based classifier had an overall accuracy of 89 percent for small-cell lung cancer patients, the researchers reported.

The Stoller Biomarker Discovery Centre, funded by the UK's Medical Research Council, recently opened to develop mass spec-based research for varied diseases.

The company will use proceeds from the placement to conduct clinical trials on its Parsortix CTC system, which has been adopted by Cancer Research UK's Mancherster Institute.

Researchers at the annual meeting of the American Association for Cancer Research discussed their efforts to use genomics to protect patients from radiotherapy toxicity.

The funds will support the development of bioinformatics tools for use in clinical trials to provide more personalized healthcare for cancer patients

The partners received £30,000 (about $46,000) in funding from the BBSRC to support their metabolomics data-sharing and analyses activities.

The results provide early evidence for the ability of haplotypes in the HLA-DRB1 gene to predict outcome and drug response, which will have to be further replicated.

Cancer-ID is a newly created consortium tasked with validating blood-based biomarkers, such as CTC, cfDNA, and miRNA to bring liquid biopsies into the clinic.

NEW YORK (GenomeWeb) – The University of Manchester today said that it has been awarded £24 million ($38.5 million), including funding for omics-directed projects, from the UK government.

Pages

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.